Introduction/ objectivesAlzheimer's disease (AD) is characterised by a progressive decline in cognitive abilities, especially learning and memory. To validate the zebrafish as a suitable model organism for AD, the study examined the effects of two neurotoxin agents, aluminium chloride (AlCl3) and okadaic acid (OKA). In the full experimental design, both neurotoxins were administered intraperitoneally at three distinct doses (low, medium, and high) twice weekly for 21 days. At three time points, behavioural tasks were conducted on day 7 (short duration), day 14 (moderate duration), and day 21 (long duration). The behavioural tasks consisted of a novel tank test lasting six minutes, followed by a T-maze tank test lasting five minutes. MethodsIn this article, the T-maze tank test was discussed in detail to evaluate which neurotoxins and their optimal dosages are impactful in developing a zebrafish AD model towards learning and memory functions. This evaluation measured four parameters: the amount of time spent in the wrong arm, the total distance travelled in the deeper chamber, and the 3-h and 24-h inflexion ratios. ResultsIn summary, a 100 nM dosage of OKA with a maximum of 21 days of evaluation resulted in significant (p < 0.05) outcomes in all parameters evaluated. The longest duration was spent in the wrong arm, accompanied by a reduction in the total distance travelled in the deeper chamber and a decreasing pattern in the 3-h and 24-h inflexion ratios. ConclusionThese observations suggest that OKA is the optimal choice of neurotoxin for a validated and optimised zebrafish AD model.